Restless legs syndrome screening: Difference between revisions
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | There is insufficient evidence to recommend routine screening for [disease/malignancy]. | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | There is insufficient evidence to recommend routine screening for [disease/malignancy]. | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | ||
* | *Chronically dialyzed patients | ||
*[Condition 2] | *[Condition 2] | ||
*[Condition 3] | *[Condition 3] |
Revision as of 16:05, 5 April 2018
Restless legs syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Restless legs syndrome screening On the Web |
American Roentgen Ray Society Images of Restless legs syndrome screening |
Risk calculators and risk factors for Restless legs syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- Chronically dialyzed patients
- [Condition 2]
- [Condition 3]